Our History
Focused on data-led automation of fulfilment services for complex, customised and compliant kitting for the pharma services sector, RDi has developed its capability to become a global leader in its field.
For nearly two decades, RDi has supported healthcare systems in providing patient and population testing solutions and services. Our combination of experienced solutions architects, data processors and developers, allied to our self-developed automation infrastructure offers our customers comprehensive end-to-end capability to deliver their requirements.
RDi delivers data-led customisation, complexity and capability in a fully regulated and compliant environment.
Our Story
Our story began in 2004 when RDi was formed as REAL Digital International with a clear vision to cater to the emerging data-driven communications sector.
In 2008, RDi took a significant step forward by producing test kits for the Bowel Cancer Screening Programme in England, contributing to the early detection and prevention of this life-threatening disease.
By 2010, our dedication to automation led to the development of innovative technology for on-demand production of SIM card packaging and fulfilment, revolutionising the telecom industry.
Continuing our commitment to cutting-edge solutions, in 2012, we built a comprehensive portal for dynamic SIM card number allocation, planning, and centralised stock control, streamlining supply chain operations for our clients.
Our desire to make a broader impact on healthcare led us to embark on a global search for technology to pack medical sample test kits, dynamically, on-demand, however, there was nothing available.
Undeterred, we took matters into our own hands and began designing and developing a groundbreaking automated production line for medical sample test kits in 2014.
The following years saw tremendous progress as we commissioned the build of an innovative automated test kit production line in 2017.
We launched an analytics platform in 2018, providing end-to-end visibility of post-fulfilment activity across multi-channels.
In 2019, we installed our first IPL line, enabling high-speed production of medical sample collection kits for FIT testing for bowel cancer screening.
We further bolstered our capabilities by installing a second IPL line to meet increasing demand.
As our expertise expanded, so did our ambitions. In 2021, we installed two additional automated production lines to serve the broader commercial market in the medical sample industry, solidifying our position as a leader in healthcare kitting. The same year, we successfully completed a management buyout (MBO), empowering us to pursue further growth and development.
In line with our commitment to develop and grow, we acquired MedDX, broadening our portfolio of healthcare kitting and component capabilities. This strategic move allowed us to better serve the evolving needs of the healthcare industry. Additionally, we reached a significant milestone by producing our 100 millionth unique healthcare sampling kit.
Building upon our success, we continued to expand our reach in 2023 by acquiring Shuttlepac, further strengthening our portfolio in medical sample transport components. This acquisition enabled us to offer end-to-end solutions that support the drive towards more sustainable solutions in sample collection.